These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21450357)

  • 1. Is monitoring milrinone therapy useful in advanced heart failure?
    Vazir A; Leaver N; Lyster H; Alexanian A; Wilton P; Banner NR
    Int J Cardiol; 2011 Jun; 149(3):380-1. PubMed ID: 21450357
    [No Abstract]   [Full Text] [Related]  

  • 2. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
    Ahmad T; Patel CB; Milano CA; Rogers JG
    Circulation; 2012 Jun; 125(23):2948-55. PubMed ID: 22689932
    [No Abstract]   [Full Text] [Related]  

  • 3. Milrinone in advanced heart failure: dose and therapeutic monitor outside intensive care unit.
    Charisopoulou D; Leaver N; Banner NR
    Angiology; 2014 Apr; 65(4):343-9. PubMed ID: 23620310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous milrinone infusion during preoperative anti-inflammatory therapy in inflammatory aortic aneurysm complicating severe congestive heart failure.
    Takeno M; Takagi S; Sakuragi S; Suzuki S; Tsutsumi Y; Nonogi H; Goto Y
    Heart Vessels; 2002 Nov; 17(1):42-4. PubMed ID: 12434201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bridge for the 21st century in heart transplantation?
    Felker GM; O'connor CM
    Am Heart J; 2003 Feb; 145(2):198-9. PubMed ID: 12595831
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heart function and clinical observations of patients with severe congestive heart failure treated with milrinone].
    Lu G; Zheng Z; Zhang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):27-9. PubMed ID: 10322703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home inotropic therapy in children.
    Berg AM; Snell L; Mahle WT
    J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy Support of a Pediatric Patient Receiving Milrinone at Home.
    Xue A; Dersch-Mills D; Tsang C; Greenway SC
    Can J Hosp Pharm; 2016; 69(5):415-419. PubMed ID: 27826160
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction.
    Cox ZL; Calcutt MW; Morrison TB; Akers WS; Davis MB; Lenihan DJ
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):433-8. PubMed ID: 23695773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
    Brozena SC; Twomey C; Goldberg LR; Desai SS; Drachman B; Kao A; Popjes E; Zimmer R; Jessup M
    J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion therapy with milrinone in the home care setting for patients who have advanced heart failure.
    Boger JE; DeLuca SL; Watkins DF; Vershave KK; Thomley AM
    J Intraven Nurs; 1997; 20(3):148-54. PubMed ID: 9214927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
    Curley M; Liebers J; Maynard R
    J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods].
    Barros IC; Freitas EM; Rassi S; Carneiro WJ; Rodrigues CR; Honório TC; Teixeira Lde S; Rodríguez V; Cunha LC
    Farm Hosp; 2014 Jan; 38(1):38-43. PubMed ID: 24483858
    [No Abstract]   [Full Text] [Related]  

  • 17. Milrinone, a bridge to heart transplantation.
    Watson DM; Sherry KM; Weston GA
    Anaesthesia; 1991 Apr; 46(4):285-7. PubMed ID: 2024747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of papillary muscle sling concept in an infant as a biological bridge to transplantation.
    Chi NH; Huang SC; Yu HY; Chen YS; Wang SS
    Ann Thorac Surg; 2005 Jan; 79(1):337-9. PubMed ID: 15620976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy.
    Bhat G
    ASAIO J; 2006; 52(6):677-81. PubMed ID: 17117058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic heart failure and the quality of life.
    Pritzker MR
    N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.